Scientific Committee

Scientific Chair: Rachael Lawrance (Adelphi Values), Conference Chair: Kate Taylor (Amgen)

The Scientific committee organises a number of one-day scientific meetings, webinars and the annual conference as well as joint meetings with other professional bodies each year. The topics of these meetings include a diverse variety of statistical techniques and applications relevent to PSI members working in clinical phase I-IV drug development & reimbursement and also a cover much wider remit applicable to the roles in the healthcare industry.

Meetings

The Scientific Committee meets each month and alternates between teleconferences and face to face meetings primarily in London or the surrounding area.

Composition

The Scientific Committee is composed of the following members: 

Adam Crisp (GlaxoSmithKline)
Amitava Mukhopadhyay (Cytel India)
David Lawrence (Novartis)
Emanuella Pozzi (Roche)
Ioulietta Mulligan (Worldwide Clinical Trials)
Jennifer Gilbride (GlaxoSmithKline)
Julia Saperia (MHRA)
Kate Taylor (Amgen)  
Lynsey Womersley (Phastar)
Maria Efstathiou (IQVIA)
Martin Jenkins (AstraZeneca)
Mouna Akacha (Novartis)
Paul Terrill (Cytel UK)
Rachael Lawrance (Adelphi Values) 
Rosie Leach (Numerus)
Russell Jones (Orchard Therapeutics)
Sarah Williams (Roche)
Sue Todd (Reading University)
Tobias Mütze (Novartis)
Tom Burnett (Lancaster University)

Upcoming Events

PSI Webinar: Master protocols - theory, application and regulatory considerations

For this webinar, PSI brings together experts on master protocols from the pharmaceutical industry, academia, and regulatory agencies.

Introduction To Industry Training Course 2020

The ITIT course will take 25 delegates new to the industry on a complete drug development experience from discovery to marketing. They will visit 6 companies to learn about 6 topics from experts in their field. The ITIT course will have 3 sessions in continental Europe and 3 sessions in the UK. The start of the 2020-2021 course will be delayed until face-to-face meetings with up to 30 people are permitted and companies are allowing travel again.

PSI Webinar: Patient preference studies

In this webinar you will hear an introduction to what a patient preference study is as well as an overview of where this type of study can inform regulatory decision making. This will be followed by 2 examples looking at potential approaches to eliciting patient preference.

PSI Vaccine SIG Webinar: Statistical Topics on COVID-19 Therapeutic and Vaccine Clinical Trials

We are delighted to be joined by Frank Harrell who will present 'Sequential Bayesian Designs for Rapid Learning in COVID-19 Therapeutic Trials'; and also by Dean Follmann, who will present on 'Statistical Aspects of COVID-19 Vaccine Trials'. Join us for this insightful and highly topical webinar.

Joint PSI, EFSPI & ASA BIOP Webinar: Estimands

PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.

Latest Jobs

Senior Research Statistician

As a member of the Statistical Sciences and Modeling (SSM) group, provide statistical technical support to projects on complex problems and methods.

Statisticians - Oncology

Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.

Therapeutic Area Global Expert Statistician - CNS & Retinopathies

You are looking for a new professional challenge - we offer you this interesting position in a global company that has been awarded several times the status of best employer.